Among the most helpful and popular features of the Red Book are its tables, algorithms, charts, and graphs. To make these tools more accessible and user-friendly at the point of care, the American Academy of Pediatrics is pleased to introduce the new Red Book Pediatric Infectious Diseases Clinical Decision Support Chart.
This handy resource collects many of the most clinically useful tables, algorithms, and other items from the latest edition of Red Book and presents them in an enlarged, enhanced, colorized format that is lightweight, portable, and easy to navigate.
Additionally, new tables have been created exclusively for this chart, synthesizing important clinical information from the Red Book text.
15 information-rich topics include:
- Staphylococcal Infections
- Streptococcal Infections
- Diarrheal Infections
- Immunizations
- Antibiotic Prophylaxis
- Immune Globulin
- Immune Globulin
- Kawasaki Disease
- Tuberculosis
- Lyme Disease
- Varicella-Zoster
- Zika
- Fungal Infections
- Genital and Neonatal Herpes
- Syphilis
- Immunocompromised Children and Adolescents
The content featured in these 15 tabs has been reviewed by the Red Book editors to ensure consistency with AAP policy.
This convenient flip chart provides pediatric health care professionals with point-of-care guidance on the assessment, prevention, and treatment of childhood infectious diseases. The content featured in these 15 information-rich tabs collects many of the most clinically useful tables, algorithms, and other items from the Red Book and presents them in an enlarged, enhanced, colorized format that is lightweight, portable, and easy to navigate.
David W. Kimberlin, MD, FAAP is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), an international network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome. Studies conducted by the CASG have led to new drug indications and label changes for acyclovir, valganciclovir, and oseltamivir, and non-CASG studies conducted by Dr. Kimberlin also have led to label changes for valacyclovir. Dr. Kimberlin is Editor of the 2018 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 edition, and was an Associate Editor of the 2012 and 2009 editions. Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society (PIDS), which is the world's largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children. He also serves as Vice Chair for Clinical and Translational Research in the UAB Department of Pediatrics, where he holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases and is Co-Director of the Division of Pediatric Infectious Diseases.
Daugiau apie elektronines knygas